Synthetic biology startups are companies that use engineered biological systems, such as microorganisms or cells, to produce a wide range of products and services. These can include biofuels, pharmaceuticals, chemicals, textiles, and more.
These startups address challenges such as sustainable production of materials, development of bio-based products that are more environmentally friendly than their chemical counterparts, and the creation of personalized medicine through tailored biological solutions.
Startups in synthetic biology employ techniques from genetic engineering, molecular biology, and computer science to design and construct new biological parts, devices, and systems. They then integrate these components into living organisms to create novel functions or improve existing ones.
Manufacturing processes often involve genetic modification of microorganisms in bioreactors. This can be complex due to regulatory requirements and the need for precise control over environmental conditions.
The build process typically includes designing DNA sequences, synthesizing these sequences, integrating them into host organisms, and optimizing the expression levels of desired traits through iterative testing and refinement.
Field units draw low hundreds of watts; fabrication is energy-intensive due to vacuum baking. Overall operational power consumption is moderate but can be optimized through process improvements.
Ranges and qualitative terms only — verify power figures against vendor datasheets.
No companies curated for this tile yet.
Curated names only — none are invented. Use the link to find more.
Cost drivers only — no verified dollar figures are shown. Check live sources for prices.
Illustrative — search real, dated examples rather than trusting a generated story.
Live searches — we don't list papers we can't verify.
Live patent searches — filings are never listed from memory.
Verify against primary sources only.
Source: curated technology intelligence stream with tracked references.